Enimmune corporation PEG Ratio

Enimmune corporation (6564.TWO) currently reports a PEG ratio of 20.33. That is below the Healthcare sector average of 27.75. Use the charts on this page to explore Enimmune corporation's PEG ratio history and peer comparisons.

Enimmune corporation's PEG ratio of 20.33 is lower than the Healthcare sector average of 27.75. That is roughly 26.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The PEG ratio is a valuation multiple that relates Enimmune corporation's market price to a fundamental measure such as earnings, sales, or book value. At 20.33, 6564.TWO can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current PEG ratio of 20.33, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 27.75. From there, open related valuation or income-statement pages for Enimmune corporation, and consider following 6564.TWO for alerts when major investors trade the stock.

Enimmune corporation is classified in the Healthcare sector. On PEG ratio, it currently shows 20.33 versus a sector average near 27.75. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6564.TWO with unrelated industries.